News

The blood cancer multiple myeloma, which involves infection-fighting plasma cells in the bone marrow, affects only about 1% of all cancers -- predominantly individuals over age 65. The disease ...
Yelak Biru was diagnosed with multiple myeloma at 25 and given just a few years to live. Thirty years later, he's thriving.
"Multiple myeloma is a malignancy (cancer) often associated with symptoms such as anemia, hypercalcemia and renal (kidney) failure. Smoldering multiple myeloma has many features of malignancy ...
Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...
As the authors reported in Radiology Case Reports, the patient had no history of cancer and had no pain, weakness, numbness, ...
By monitoring patients’ CBC and other symptoms, nurses and advanced practice providers can spot early indicators of Parkinsonism risk, per Yi Lin, MD, PhD.
In a small study, a third of the participants with multiple myeloma, a common blood cancer which has up until now been deemed incurable, seem to have had their cancer disappear, The New York Times ...
Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...
Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk for developing ...